Jiangsu Aidea Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Jiangsu Aidea Pharmaceutical has a total shareholder equity of CN¥1.1B and total debt of CN¥395.4M, which brings its debt-to-equity ratio to 36.5%. Its total assets and total liabilities are CN¥1.7B and CN¥584.7M respectively.
Key information
36.5%
Debt to equity ratio
CN¥395.44m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥331.87m |
| Equity | CN¥1.08b |
| Total liabilities | CN¥584.68m |
| Total assets | CN¥1.67b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688488's short term assets (CN¥796.6M) exceed its short term liabilities (CN¥516.6M).
Long Term Liabilities: 688488's short term assets (CN¥796.6M) exceed its long term liabilities (CN¥68.1M).
Debt to Equity History and Analysis
Debt Level: 688488's net debt to equity ratio (5.9%) is considered satisfactory.
Reducing Debt: 688488's debt to equity ratio has increased from 21.6% to 36.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 688488 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 688488 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 41.6% each year.